EDGAR Filing Documents for 0001193125-15-291641

Form CORRESP - Correspondence:

SEC Accession No. 0001193125-15-291641

Filing Date

2015-08-14

Accepted

2015-08-14 15:20:33

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		filename1.htm	CORRESP	305521
2	GRAPHIC	g37616tx_logo.jpg	GRAPHIC	3003
3	GRAPHIC	g37616tx_pg001.jpg	GRAPHIC	17267
	Complete submission text file	0001193125-15-291641.txt		334557

Mailing Address LEBERSTRASSE 20 VIENNA C4 1110

Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0

Nabriva Therapeutics AG (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations